APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contrast Agents for Magnetic Resonance Imaging (MRI)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Research Report 2026

22 December 2025127 pages

Choose your research edition.

Industry ResearchContrast Agents for Magnetic Resonance Imaging (MRI) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Contrast Agents for Magnetic Resonance Imaging (MRI) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application

Radiology

Interventional Radiology

Interventional Cardiology

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Contrast Agents for Magnetic Resonance Imaging (MRI) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units) of Manufacturers (2021-2026) Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue of Manufacturers (2021-2026) Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Product Type & Application Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Daiichi Sankyo (Japan) Company Information Table 19. Daiichi Sankyo (Japan) Business Overview Table 20. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 22. Daiichi Sankyo (Japan) Recent Developments Table 23. Bayer HealthCare (Germany) Company Information Table 24. Bayer HealthCare (Germany) Business Overview Table 25. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 27. Bayer HealthCare (Germany) Recent Developments Table 28. Unijules Life Sciences (India) Company Information Table 29. Unijules Life Sciences (India) Business Overview Table 30. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 32. Unijules Life Sciences (India) Recent Developments Table 33. Taejoon Pharm (South Korea) Company Information Table 34. Taejoon Pharm (South Korea) Business Overview Table 35. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 37. Taejoon Pharm (South Korea) Recent Developments Table 38. Spago Nanomedicine (Sweden) Company Information Table 39. Spago Nanomedicine (Sweden) Business Overview Table 40. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 42. Spago Nanomedicine (Sweden) Recent Developments Table 43. Magnus Health (India) Company Information Table 44. Magnus Health (India) Business Overview Table 45. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 47. Magnus Health (India) Recent Developments Table 48. Lantheus (US) Company Information Table 49. Lantheus (US) Business Overview Table 50. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 52. Lantheus (US) Recent Developments Table 53. Jodas (India) Company Information Table 54. Jodas (India) Business Overview Table 55. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 57. Jodas (India) Recent Developments Table 58. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 59. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 60. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 62. J.B. Chemicals and Pharmaceuticals (India) Recent Developments Table 63. Guerbet (France) Company Information Table 64. Guerbet (France) Business Overview Table 65. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 67. Guerbet (France) Recent Developments Table 68. GE Healthcare (US) Company Information Table 69. GE Healthcare (US) Business Overview Table 70. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 72. GE Healthcare (US) Recent Developments Table 73. Bracco Imaging (Italy) Company Information Table 74. Bracco Imaging (Italy) Business Overview Table 75. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 77. Bracco Imaging (Italy) Recent Developments Table 78. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026) & (k units) Table 80. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2026) Table 81. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2027-2032) & (k units) Table 82. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2027-2032) Table 83. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2026) Table 85. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2027-2032) Table 87. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 89. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 90. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 94. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 95. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 99. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 100. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 104. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 105. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 109. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 110. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 113. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 114. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2026) Table 115. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2027-2032) Table 116. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2026) Table 119. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2027-2032) Table 120. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2026) & (US$/unit) Table 121. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2027-2032) & (US$/unit) Table 122. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 123. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 124. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2026) Table 125. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2027-2032) Table 126. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2026) Table 129. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2027-2032) Table 130. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2026) & (US$/unit) Table 131. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2027-2032) & (US$/unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List Table 135. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List Table 136. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends Table 137. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers Table 138. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Contrast Agents for Magnetic Resonance Imaging (MRI) Product Image Figure 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size (2021-2032) & (US$ Million) Figure 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2021-2032) & (k units) Figure 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (US$/unit) & (2021-2032) Figure 9. Microbubble Contrast Media Product Image Figure 10. Gadolinium-based Contrast Media Product Image Figure 11. Iodinated Contrast Media Product Image Figure 12. Barium-based Contrast Media Product Image Figure 13. Radiology Product Image Figure 14. Interventional Radiology Product Image Figure 15. Interventional Cardiology Product Image Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Contrast Agents for Magnetic Resonance Imaging (MRI) Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region in 2025 Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region in 2025 Figure 23. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country in 2025 Figure 24. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 25. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2021-2032) Figure 26. United States Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country in 2025 Figure 30. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 31. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2021-2032) Figure 32. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country in 2025 Figure 43. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2021-2032) Figure 45. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country in 2025 Figure 54. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 55. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2021-2032) Figure 56. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country in 2025 Figure 60. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2021-2032) Figure 62. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032) Figure 68. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032) Figure 69. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (US$/unit) by Type (2021-2032) Figure 70. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032) Figure 71. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032) Figure 72. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (US$/unit) by Application (2021-2032) Figure 73. Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Figure 74. Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size (2021-2032)
  4. 2.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2021-2032)
  5. 2.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Average Price (2021-2032)
  6. 2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Microbubble Contrast Media
  9. 2.3.3 Gadolinium-based Contrast Media
  10. 2.3.4 Iodinated Contrast Media
  11. 2.3.5 Barium-based Contrast Media
  12. 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Radiology
  15. 2.4.3 Interventional Radiology
  16. 2.4.4 Interventional Cardiology
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Product Type & Application
  8. 3.8 Global Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Established Date
  9. 3.9 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Daiichi Sankyo (Japan)
  2. 4.1.1 Daiichi Sankyo (Japan) Company Information
  3. 4.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 4.1.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  6. 4.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 4.2 Bayer HealthCare (Germany)
  8. 4.2.1 Bayer HealthCare (Germany) Company Information
  9. 4.2.2 Bayer HealthCare (Germany) Business Overview
  10. 4.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  12. 4.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 4.3 Unijules Life Sciences (India)
  14. 4.3.1 Unijules Life Sciences (India) Company Information
  15. 4.3.2 Unijules Life Sciences (India) Business Overview
  16. 4.3.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  18. 4.3.5 Unijules Life Sciences (India) Recent Developments
  19. 4.4 Taejoon Pharm (South Korea)
  20. 4.4.1 Taejoon Pharm (South Korea) Company Information
  21. 4.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 4.4.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  24. 4.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 4.5 Spago Nanomedicine (Sweden)
  26. 4.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 4.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 4.5.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  30. 4.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 4.6 Magnus Health (India)
  32. 4.6.1 Magnus Health (India) Company Information
  33. 4.6.2 Magnus Health (India) Business Overview
  34. 4.6.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  36. 4.6.5 Magnus Health (India) Recent Developments
  37. 4.7 Lantheus (US)
  38. 4.7.1 Lantheus (US) Company Information
  39. 4.7.2 Lantheus (US) Business Overview
  40. 4.7.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  42. 4.7.5 Lantheus (US) Recent Developments
  43. 4.8 Jodas (India)
  44. 4.8.1 Jodas (India) Company Information
  45. 4.8.2 Jodas (India) Business Overview
  46. 4.8.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  48. 4.8.5 Jodas (India) Recent Developments
  49. 4.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 4.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 4.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 4.9.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  54. 4.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 4.10 Guerbet (France)
  56. 4.10.1 Guerbet (France) Company Information
  57. 4.10.2 Guerbet (France) Business Overview
  58. 4.10.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  60. 4.10.5 Guerbet (France) Recent Developments
  61. 4.11 GE Healthcare (US)
  62. 4.11.1 GE Healthcare (US) Company Information
  63. 4.11.2 GE Healthcare (US) Business Overview
  64. 4.11.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  66. 4.11.5 GE Healthcare (US) Recent Developments
  67. 4.12 Bracco Imaging (Italy)
  68. 4.12.1 Bracco Imaging (Italy) Company Information
  69. 4.12.2 Bracco Imaging (Italy) Business Overview
  70. 4.12.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  72. 4.12.5 Bracco Imaging (Italy) Recent Developments
5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Scenario by Region
  1. 5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021-2032
  3. 5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021-2026
  4. 5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2027-2032
  5. 5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2021-2032
  6. 5.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2021-2026
  7. 5.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2027-2032
  8. 5.4 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
  9. 5.4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  11. 5.4.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
  16. 5.5.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  18. 5.5.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
  41. 5.7.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  43. 5.7.3 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  2. 6.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  5. 6.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  2. 7.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  5. 7.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Analysis
  2. 8.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process
  5. 8.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
  8. 8.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
9 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Analyzing Market Dynamics
  1. 9.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
  2. 9.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers
  3. 9.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges
  4. 9.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst